MariMed (MRMD) 10-Q 9 Aug 22 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2022	Aug. 05, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2022
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	0-54433
Entity Registrant Name	MARIMED INC.
Entity Central Index Key	0001522767
Entity Tax Identification Number	27-4672745
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	10 Oceana Way
Entity Address, City or Town	Norwood
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02062
City Area Code	617
Local Phone Number	795-5140
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		338,693,855

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 7,911	$ 29,683
Accounts receivable, net	5,297	1,666
Deferred rents receivable	737	1,678
Notes receivable, current portion	132	127
Inventory	15,889	9,768
Investments, current	525	251
Other current assets	3,059	1,440
Total current assets	33,550	44,613
Property and equipment, net	69,132	62,150
Intangible assets, net	9,898	162
Goodwill	8,079	2,068
Notes receivable, net of current	9,116	8,987
Operating lease right-of-use assets	5,071	5,081
Finance lease right-of-use assets	541	46
Other assets	491	98
Total assets	135,878	123,205
Current liabilities:
Mortgages and notes payable, current portion	2,734	1,410
Accounts payable	7,624	5,099
Accrued expenses and other	3,473	3,149
Income taxes payable	10,001	16,467
Operating lease liabilities, current portion	1,201	1,071
Finance lease liabilities, current portion	180	27
Total current liabilities	25,213	27,223
Mortgages and notes payable, net of current	20,629	17,262
Operating lease liabilities, net of current	4,420	4,574
Finance lease liabilities, net of current	338	22
Other liabilities	100	100
Total liabilities	50,700	49,181
Commitments and contingencies
Mezzanine equity:
Total mezzanine equity	37,725	37,725
Stockholders’ equity
Common stock, $0.001 par value; 700,000,000 shares authorized; 338,693,855 and 334,030,348 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	339	334
Additional paid-in capital	139,951	134,920
Accumulated deficit	(91,381)	(97,392)
Noncontrolling interests	(1,456)	(1,563)
Total stockholders’ equity	47,453	36,299
Total liabilities, mezzanine equity and stockholders’ equity	135,878	123,205
Series B Convertible Preferred Stock [Member]
Mezzanine equity:
Total mezzanine equity	14,725	14,725
Series C Convertible Preferred Stock [Member]
Mezzanine equity:
Total mezzanine equity	$ 23,000	$ 23,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	38,875,451	38,875,451
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	700,000,000	700,000,000
Common stock, shares issued	338,693,855	334,030,348
Common stock, shares outstanding	338,693,855	334,030,348
Series B Convertible Preferred Stock [Member]
Mezzanine equity, par value	$ 0.001	$ 0.001
Mezzanine equity, shares authorized	4,908,333	4,908,333
Mezzanine equity, shares issued	4,908,333	4,908,333
Mezzanine equity, shares outstanding	4,908,333	4,908,333
Series C Convertible Preferred Stock [Member]
Mezzanine equity, par value	$ 0.001	$ 0.001
Mezzanine equity, shares authorized	12,432,432	12,432,432
Mezzanine equity, shares issued	6,216,216	6,216,216
Mezzanine equity, shares outstanding	6,216,216	6,216,216

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenue	$ 32,986	$ 32,569	$ 64,268	$ 57,212
Cost of revenue	17,981	13,163	32,287	24,620
Gross profit	15,005	19,406	31,981	32,592
Operating expenses:
Personnel	3,382	2,058	6,424	3,785
Marketing and promotion	809	270	1,452	495
General and administrative	5,565	4,282	11,793	7,453
Acquisition-related and other	754		754
Bad debt		794	14	1,819
Total operating expenses	10,510	7,404	20,437	13,552
Income from operations	4,495	12,002	11,544	19,040
Interest and other (expense) income:
Interest expense	(440)	(265)	(753)	(1,777)
Interest income	318	36	481	70
Other (expense) income, net	(727)	(371)	275	(417)
Total interest and other (expense) income	(849)	(600)	3	(2,124)
Income before income taxes	3,646	11,402	11,547	16,916
Provision for income taxes	1,750	3,813	5,410	5,017
Net income	1,896	7,589	6,137	11,899
Net income attributable to noncontrolling interests	73	96	126	186
Net income attributable to common stockholders	$ 1,823	$ 7,493	$ 6,011	$ 11,713
Net income per share attributable to common stockholders:
Basic	$ 0.01	$ 0.02	$ 0.02	$ 0.04
Diluted	$ 0	$ 0.02	$ 0.02	$ 0.03
Weighted average common shares outstanding:
Basic	337,497	324,267	336,137	321,741
Diluted	379,626	370,257	379,225	365,324

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Common Stock Subscribed But Not Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 314	$ 5	$ 112,975	$ (104,617)	$ (577)	$ 8,100
Beginning balance, shares at Dec. 31, 2020	314,418,812	11,413
Exercise of stock options			9			9
Exercise of stock options, shares	82,885,000
Release of shares under stock grants
Release of shares under stock grants, shares	6,877,000
Conversion of promissory notes to stock, shares						12,542,126
Distributions to non-controlling interests					(183)	$ (183)
Stock-based compensation			1,600			1,600
Net income				11,713	186	11,899
Issuance of subscribed shares		$ (5)	5
Issuance of subscribed shares, shares	11,413	(11,413)
Exercise of warrants	$ 1		60			61
Exercise of warrants, shares	698,812
Conversion of debentures payable to equity	$ 5		1,352			1,357
Coversion of debentures payable to equity, shares	4,610,645,000
Conversion of promissory notes to equity	$ 7		2,253			2,260
Conversion of promissory notes to equity, shares	6,937,400,000
Stock issued to settle obligations			53			53
Stock issued to settle obligations, shares	71,691,000
Equity issuance costs			(387)			(387)
Ending balance, value at Jun. 30, 2021	$ 327		117,920	(92,904)	(574)	24,769
Ending balance, shares at Jun. 30, 2021	326,838,535
Beginning balance, value at Dec. 31, 2020	$ 314	$ 5	112,975	(104,617)	(577)	8,100
Beginning balance, shares at Dec. 31, 2020	314,418,812	11,413
Ending balance, value at Dec. 31, 2021	$ 334		134,920	(97,392)	(1,563)	36,299
Ending balance, shares at Dec. 31, 2021	334,030,348
Exercise of stock options			3			$ 3
Exercise of stock options, shares	10,000					39,899,423
Cashless exercise of stock options
Cashless exercise of stock options, shares	200,000
Cashless exercise of warrants
Cashless exercise of warrants, shares	234,961
Release of shares under stock grants
Release of shares under stock grants, shares	356,938,000
Shares issued as purchase consideration - business acquisition	$ 3		1,497			1,500
Shares issued as purchase consideration - business acquisition, shares	2,343,750,000
Purchase of minority interests in certain of the Company’s subsidiaries			(2,165)		165	(2,000)
Stock issued as payment of fees	$ 1		273			274
Stock issued as payment of fees, shares	375,000,000
Conversion of promissory notes to stock	$ 1		399			$ 400
Conversion of promissory notes to stock, shares	1,142,858,000					12,542,126
Distributions to non-controlling interests					(184)	$ (184)
Stock-based compensation			5,024			5,024
Net income				6,011	126	6,137
Ending balance, value at Jun. 30, 2022	$ 339		$ 139,951	$ (91,381)	$ (1,456)	$ 47,453
Ending balance, shares at Jun. 30, 2022	338,693,855

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income attributable to common stockholders	$ 6,011	$ 11,713
Net income attributable to noncontrolling interests	126	186
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization of property and equipment	1,552	963
Amortization of intangible assets	425	346
Stock-based compensation	5,024	1,600
Amortization of warrants attached to debt		539
Amortization of beneficial conversion feature		177
Amortization of original issue discount		52
Bad debt expense	14	1,819
Fees paid with stock	274
Loss on obligations settled with equity		3
(Gain) loss on changes in fair value of investments	679	415
Other investment income	(954)
Changes in operating assets and liabilities:
Accounts receivable, net	(3,554)	(3,230)
Deferred rents receivable	99	125
Inventory	(1,795)	(2,398)
Other current assets	(1,267)	(1,373)
Other assets	(392)	(17)
Accounts payable	2,024	1,699
Accrued expenses and other	180	4,973
Income taxes payable	(6,467)
Net cash provided by operating activities	1,979	17,592
Cash flows from investing activities:
Purchases of property and equipment	(7,854)	(7,976)
Business acquisitions, net of cash acquired	(12,746)
Purchases of cannabis licenses	(330)	(638)
Proceeds from notes receivable	73
Interest on notes receivable		119
Net cash used in investing activities	(20,857)	(8,495)
Cash flows from financing activities:
Proceeds from issuance of preferred stock		23,000
Equity issuance costs		(387)
Proceeds from issuance of promissory notes		35
Principal payments of mortgages and promissory notes	(611)	(16,098)
Proceeds from exercise of stock options	3	9
Proceeds from exercise of warrants		61
Repayment of loans from related parties		(1,158)
Principal payments of finance leases	(102)	(18)
Redemption of minority interests	(2,000)
Distributions	(184)	(183)
Net cash (used in) provided by financing activities	(2,894)	5,261
Net (decrease) increase in cash and cash equivalents	(21,772)	14,358
Cash and equivalents, beginning of year	29,683	2,999
Cash and cash equivalents, end of period	7,911	17,357
Supplemental disclosure of cash flow information:
Cash paid for interest	647	1,405
Cash paid for income taxes	11,877	419
Non-cash activities:
Stock issued as purchase consideration	1,500
Conversion of promissory notes	400	2,260
Conversions of debentures payable		1,356
Operating lease right-of-use assets and liabilities	322	466
Finance lease right-of-use assets and liabilities	519
Common stock issued to settle obligations		51
Issuance of common stock associated with subscriptions		5
Cashless exercise of warrants		180
Cashless exercise of stock options		$ 53

BASIS OF PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
BASIS OF PRESENTATION	(1) BASIS OF PRESENTATION Business MariMed Inc. (“MariMed” or the “Company”) is a multi-state operator in the United States cannabis industry. MariMed develops, operates, manages, and optimizes over 300,000 Basis of Presentation In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in accordance with accounting principles generally accepted in the United States of America (“GAAP”). On April 27, 2022 (the “Kind Acquisition Date”), the Company acquired Kind Therapeutics USA (“Kind”). The financial results of Kind are included in the Company’s condensed consolidated financial statements for the period subsequent to the Kind Acquisition Date. Interim results are not necessarily indicative of results for the full fiscal year or any future interim period. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “Annual Report”), which was filed with the U.S. Securities and Exchange Commission (“SEC”) on March 16, 2022. Certain reclassifications, not affecting previously reported net income or cash flows, have been made to the previously issued financial statements to conform to the current period presentation. Significant Accounting Policies The Company’s significant accounting policies are disclosed in Note 2 to the Consolidated Financial Statements included in the Annual Report. There were no material changes to the significant accounting policies during the three- or six-month periods ended June 30, 2022. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of MariMed and its wholly- and majority-owned subsidiaries. Intercompany transactions and balances have been eliminated in consolidation. Noncontrolling interests represent third-party minority ownership interests in the Company’s majority-owned consolidated subsidiaries. Net income attributable to noncontrolling interests is reported in the condensed consolidated statements of operations, and the value of minority-owned interests are presented as a component of equity within the condensed consolidated balance sheets. Use of Estimates and Judgments The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenue and expenses during the reporting periods. Significant estimates and judgments relied upon in preparing these condensed consolidated financial statements include accounting for business combinations, inventory valuations, assumptions used to determine the fair value of stock-based compensation, and intangible asset and goodwill. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity date of three months or less to be cash equivalents. The fair values of these investments approximate their carrying values. At June 30, 2022 and December 31, 2021, the Company had cash of $ 0.1 5.1 5.0 Fair Value of Financial Instruments The carrying amounts of the Company’s financial instruments approximate their fair values and include cash equivalents, accounts receivable, deferred rents receivable, notes receivable, mortgages and notes payable, and accounts payable. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The three-tier fair value hierarchy is based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Level 2 Level 3 Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, Accounting Standards Updates (“ASUs”) and does not believe that the future adoption of any such ASUs will have a material impact on its financial condition or results of operations.

ACQUISITIONS

ACQUISITIONS	6 Months Ended
	Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]
ACQUISITIONS	(2) ACQUISITIONS Kind In December 2021, the Company entered into a membership interest purchase agreement with the members of Kind, the Company’s client in Maryland that holds licenses for the cultivation, production, and dispensing of medical cannabis, to acquire 100 13.5 6.5 5.0 In April 2022, the Maryland Medical Cannabis Commission approved the Company’s acquisition of Kind, and the acquisition was completed on the Kind Acquisition Date (the “Kind Acquisition”). Following the Kind Acquisition, the Maryland litigation between the Company and the members of Kind was dismissed (see Note 18). The Company believes that the Kind Acquisition allows it to expand its operations into the Maryland cannabis industry and marketplace. The Kind Acquisition has been accounted for as a business combination and the financial results of Kind have been included in the Company’s condensed consolidated financial statement for the period subsequent to the Kind Acquisition Date. The Company’s financial results for the three and six months ended June 30, 2022 include $ 1.7 0.3 A summary of the preliminary allocation of Kind Consideration to the acquired assets, identifiable intangible assets and certain assumed liabilities is as follows (in thousands): SCHEDULE OF ACQUIRED ASSETS IDENTIFIABLE INTANGIBLE ASSETS AND CERTAIN ASSUMED LIABILITIES Fair value of consideration transferred: Cash consideration: Cash paid at closing $ 10,128 Release of escrow 2,444 Severance paid from escrow 556 Less cash acquired (2,310 ) Net cash consideration 10,818 Note payable 5,634 Write-off accounts receivable 658 Write-off of deferred accounts receivable 842 Total fair value of consideration transferred $ 17,952 Fair value of assets acquired and (liabilities assumed): Current assets, net of cash acquired $ 5,047 Property and equipment 622 Intangible assets: Tradename and trademarks 2,041 Licenses and customer base 4,700 Non-compete agreements 42 Goodwill 6,011 Current liabilities (511 ) Total fair value of assets acquired and (liabilities assumed) $ 17,952 The valuation of the acquired intangible assets is inherently subjective and relies on significant unobservable inputs. The Company used an income approach to value the acquired tradename/trademarks, licenses/customer base, and non-compete intangible assets. The valuation for each of these intangible assets was based on estimated projections of expected cash flows to be generated by the assets discounted to the present value at discount rates commensurate with perceived risk. The valuation assumptions take into consideration the Company’s estimates of new markets, products and customers and its outcome through key assumptions driving asset values, including sales growth, royalty rates and other related costs. The Company is amortizing the identifiable intangible assets arising from the Kind Acquisition in relation to the expected cash flows from the individual intangible assets over their respective useful lives, which have a weighted average life of 5.77 Concurrent with entering into the Kind membership purchase agreement, the Company entered into a membership interest purchase agreement with one of the members of Kind to acquire such member’s entire equity ownership interest in (i) Mari Holdings MD LLC (“Mari-MD”), the Company’s majority-owned subsidiary that owns production and retail cannabis facilities in Hagerstown, MD and Annapolis, MD, and (ii) Mia Development LLC (“Mia”), the Company’s majority-owned subsidiary that owns production and retail cannabis facilities in Wilmington, DE. Upon the dismissal in June 2022 of the derivative claims in the DiPietro lawsuit (see Note 18), the Company paid the aggregate purchase consideration of $ 2.0 99.7 94.3 Green Growth Group Inc. In January 2022, the Company entered into a stock purchase agreement to acquire 100 1.9 1.5 100,000 In April 2022, the Illinois Department of Agriculture approved the Company’s acquisition of Green Growth, and the purchase transaction (the “Green Growth Acquisition”) was completed on May 5, 2022 (the “Green Growth Acquisition Date”). The Company paid the remaining $ 1.8 2,343,750 14,000 The Company has allocated the purchase price to its licenses/customer base intangible asset on a preliminary basis. The Company recorded approximately $ 57,000 of amortization expense in the three months ended June 30, 2022 for the intangible asset acquired based on an estimated ten-year life for such assets. Meditaurus LLC In September 2021, the Company acquired the remaining 30.0 100,000 94,000 10,000 70.0 2.8 The carrying value of the noncontrolling interest of approximately $ 975,000 Pending Transactions Beverly Asset Purchase In November 2021, the Company entered into an asset purchase agreement to acquire the cannabis license, property lease, and other assets and rights of, and to assume the liabilities and operating obligations associated with, a cannabis dispensary that is currently operating in Beverly, MA. The purchase price is comprised of 2,000,000 5.1 The purchase is contingent upon the approval of the Massachusetts Cannabis Control Commission, which is expected prior to the end of 2022. Concurrent with the execution of this agreement, the parties entered into a consulting agreement under which the Company provides certain oversight services related to the development, staffing, and operation of the business in exchange for a monthly fee. The Harvest Foundation LLC In 2019, the Company entered into a purchase agreement to acquire 100 The purchase agreement provides for a purchase price comprised of the issuance of (i) 1,000,000 1.2 400,000 Upon approval of the transfer, and the fulfillment of other closing conditions, if achieved, the ownership of Harvest will be transferred to the Company, and the operations of Harvest will begin to be consolidated into the Company’s financial statements. There is no assurance that the closing conditions to the Company’s acquisition of Harvest, including regulatory approval, will be achieved or that the acquisition will be consummated.

EARNINGS PER SHARE

EARNINGS PER SHARE	6 Months Ended
	Jun. 30, 2022
Net income per share attributable to common stockholders:
EARNINGS PER SHARE	(3) EARNINGS PER SHARE Basic earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period. Diluted net earnings per share is determined by using the weighted average number of common and dilutive common equivalent shares outstanding during the period, unless the effect is antidilutive. The calculations of shares used to compute net earnings per share were as follows (in thousands): SCHEDULE OF EARNINGS PER SHARE 2022 2021 2022 2021 Three months ended Six months ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 Weighted average shares outstanding - basic 337,497 324,267 336,137 321,741 Potential dilutive common shares 42,129 45,990 43,088 43,583 Weighted average shares outstanding - diluted 379,626 370,257 379,225 365,324

DEFERRED RENTS RECEIVABLE

DEFERRED RENTS RECEIVABLE	6 Months Ended
	Jun. 30, 2022
Deferred Rents Receivable
DEFERRED RENTS RECEIVABLE	(4) DEFERRED RENTS RECEIVABLE The Company is the lessor under operating leases which contain escalating rents over time, rent holidays, options to renew, requirements to pay property taxes, insurance and/or maintenance costs, and contingent rental payments based on a percentage of monthly tenant revenues. The Company is not the lessor under any finance leases. The Company recognizes fixed rental receipts from such lease agreements on a straight-line basis over the expected lease term. Differences between amounts received and amounts recognized are recorded in Deferred rents receivable in the condensed consolidated balance sheets. Contingent rentals are recognized only after tenants’ revenues are finalized and if such revenues exceed certain minimum levels. The Company leases the following owned properties: ● Delaware – a 45,000 expires in 2035 ● Maryland – a 180,000 expires in 2037 ● Massachusetts – a 138,000 October 2022 The Company subleases the following properties: ● Delaware – a 4,000 expiring in April 2027 ● Delaware – a 100,000 60,000 The sublease expires in March 2030, with an option to extend the term for three additional five-year periods. ● Delaware – a 12,000 The sublease expires in January 2026 and contains an option to negotiate an extension at the end of the lease term. The Company received rental payments aggregating $ 0.8 2.0 1.2 2.4 0.8 1.9 1.1 2.3 Future minimum rental receipts for non-cancellable leases and subleases as of June 30, 2022 were as follows (in thousands): SCHEDULE OF FUTURE MINIMUM RENTAL RECEIPTS FOR NON-CANCELABLE LEASES AND SUBLEASES Year ending December 31, Remainder of 2022 $ 1,085 2023 1,911 2024 1,925 2025 1,946 2026 1,868 Thereafter 11,366 Total $ 20,101

NOTES RECEIVABLE

NOTES RECEIVABLE	6 Months Ended
	Jun. 30, 2022
Receivables [Abstract]
NOTES RECEIVABLE	(5) NOTES RECEIVABLE Notes receivable, including accrued interest, at June 30, 2022 and December 31, 2021 consisted of the following (in thousands): SCHEDULE OF NOTES RECEIVABLES June 30, December 31, First State Compassion Center (initial note) $ 367 $ 403 First State Compassion Center (secondary note) 8,002 7,845 Healer LLC 879 866 Total notes receivable 9,248 9,114 Notes receivable, current portion 132 127 Notes receivable, less current portion $ 9,116 $ 8,987 First State Compassion Center The Company’s cannabis-licensed client in Delaware, First State Compassion Center (“FSCC”), issued a 10 0.7 12.5 10,000 80,000 75,000 In December 2021, the Company converted financed trade accounts receivable balances from FSCC aggregating $ 7.8 7.8 6.0 54,000 Healer LLC In March 2021, the Company was issued a promissory note in the principal amount of approximately $ 0.9 0.8 94,000 6.0 The Company has the right to offset any licensing fees payable by the Company to Healer in the event Healer fails to make any payment when due. In March 2021, the Company offset approximately $ 28,000 866,000 52,000 High Fidelity In August 2021, a $ 250,000 10.0%

INVENTORY

INVENTORY	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
INVENTORY	(6) INVENTORY Inventory at June 30, 2022 and December 31, 2021 consisted of the following (in thousands): SCHEDULE OF INVENTORY June 30, December 31, Plants $ 1,430 $ 1,015 Ingredients and other raw materials 498 262 Work-in-process 8,262 4,661 Finished goods 5,699 3,830 Total inventory $ 15,889 $ 9,768

INVESTMENTS

INVESTMENTS	6 Months Ended
	Jun. 30, 2022
Schedule of Investments [Abstract]
INVESTMENTS	(7) INVESTMENTS The Company’s investments at June 30, 2022 and December 31, 2021 were comprised of the following (in thousands): SCHEDULE OF INVESTMENTS June 30, December 31, Investments – current: Flowr Corp. (formerly Terrace Inc.) $ 124 $ 251 WM Technology Inc. 401 - Total current investments $ 525 $ 251 The Company did no Flowr Corp. (formerly Terrace Inc.) In December 2020, Terrace Inc., a Canadian cannabis entity in which the Company had an ownership interest of 8.95 0.4973 The Flowr Investment is recorded at fair value, with changes in fair value recorded as a component of Other (expense) income, net, in the condensed consolidated statements of operations. The Company recorded losses of $ 0.2 0.1 0.4 MembersRSVP LLC In January 2021, the Company and MembersRSVP LLC, an entity that develops cannabis-specific software (“MRSVP”) in which the Company owned a 23.0 11.0 In addition to the reduction of the Company’s ownership interest to 12.0 In September 2021, MRSVP sold substantially all of its assets pursuant to an asset purchase agreement. In connection with this transaction, the Company received cash proceeds of $ 1.5 0.3 As an ongoing member of MRSVP, the Company was entitled to its pro rata share of any additional consideration received by MRSVP pursuant to the asset purchase agreement, which could include securities or other forms of non-cash or in-kind consideration and holdback amounts, if and when received and distributed by MRSVP. In February 2022, the Company received 121,968 0.6

PROPERTY AND EQUIPMENT, NET

PROPERTY AND EQUIPMENT, NET	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	(8) PROPERTY AND EQUIPMENT, NET The Company’s property and equipment, net, at June 30, 2022 and December 31, 2021 was comprised of the following (in thousands): SCHEDULE OF PROPERTY AND EQUIPMENT June 30, December 31, Land $ 4,450 $ 4,450 Buildings and building improvements 38,672 35,231 Tenant improvements 16,990 9,745 Furniture and fixtures 1,973 1,888 Machinery and equipment 9,466 7,221 Construction in progress 5,897 10,569 Property and equipment, gross 77,448 69,104 Less: accumulated depreciation (8,316 ) (6,954 ) Property and equipment, net $ 69,132 $ 62,150 The amounts reported as construction in progress primarily relate to the development of facilities in Annapolis, MD, Beverly, MA and Milford, DE.

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND GOODWILL	(9) INTANGIBLE ASSETS AND GOODWILL The Company’s acquired intangible assets at June 30, 2022 consisted of the following (in thousands): SCHEDULE OF ACQUIRED INTANGIBLE ASSETS Weighted average Net amortization Accumulated carrying period (years) Cost amortization value Tradename and trademarks 3.00 $ 2,041 $ 113 $ 1,928 Licenses and customer base 8.26 8,100 169 7,931 Non-compete agreements 2.00 42 3 39 7.18 $ 10,183 $ 285 $ 9,898 Estimated future amortization expense for the Company’s intangible assets at June 30, 2022 was as follows: SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE OF INTANGIBLE ASSETS Year ending December 31, Remainder of 2022 $ 856 2023 1,712 2024 1,699 2025 1,239 2026 1,011 Thereafter 3,381 Total $ 9,898 The changes in the carrying value of the Company’s goodwill in the three months ended June 30, 2022 and 2021 were as follows (in thousands): SCHEDULE OF GOODWILL 2022 2021 Balance at January 1, $ 2,068 $ 2,068 Kind Acquisition 6,011 - Balance at June 30, $ 8,079 $ 2,068

MORTGAGES AND NOTES PAYABLE

MORTGAGES AND NOTES PAYABLE	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
MORTGAGES AND NOTES PAYABLE	(10) MORTGAGES AND NOTES PAYABLE The Company’s mortgages and notes payable are reported in the aggregate on the condensed consolidated balance sheets under the captions Mortgages and notes payable, current, and Mortgages and notes payable, net of current. Mortgages The Company’s mortgage balances, including accrued interest, at June 30, 2022 and December 31, 2021 were comprised of the following (in thousands): SCHEDULE OF MORTGAGES June 30, December 31, Bank of New England – New Bedford, MA and Middleboro, MA properties $ 12,319 $ 12,499 Bank of New England – Wilmington, DE property 1,404 1,463 DuQuoin State Bank – Anna, IL and Harrisburg, IL properties 767 778 DuQuoin State Bank – Metropolis, IL property 2,574 2,658 South Porte Bank – Mt. Vernon, IL property 814 816 Total mortgages payable 17,878 18,214 Less: Mortgages payable, current ( 1,417 ) ( 1,400 ) Mortgages payable, less current portion $ 16,461 $ 16,814 The Company maintains an amended and restated mortgage agreement with the Bank of New England with an interest rate of 6.5 August 2025 4.8 7.2 370,000 358,000 The Company maintains a second mortgage with Bank of New England that is secured by the Company’s property in Wilmington, DE (the “BNE Delaware Mortgage”). The mortgage matures in 2031 5.25 1.5 5.25 123,000 120,000 The Company maintains a mortgage with DuQuoin State Bank (“DSB”) in connection with its purchase of properties in Anna, IL and Harrisburg, IL (the “DuQuoin Mortgage”). On May 5 of each year, the DuQuoin Mortgage becomes due unless it is renewed for another year at a rate determined by DSB’s executive committee. The DuQuoin Mortgage was renewed in May 2021 at a rate of 6.75 32,000 33,000 In July 2021, the Company purchased the land and building in which it operates its cannabis dispensary in Metropolis, IL. The purchase price consisted of 750,000 705,000 1.6 2.7 matures in July 2041 6.25 30.0 70.0 78,000 73,000 In February 2020, the Company entered into a mortgage agreement with South Porte Bank for the purchase and development of a property in Mt. Vernon, IL, (the “South Porte Bank Mortgage”). Beginning in August 2021, pursuant to the amendment of the South Porte Bank Mortgage, the monthly payments of principal and interest aggregated approximately $ 6,000 Promissory Notes Promissory Note Retirements In March 2021, utilizing a portion of the proceeds from the Hadron Transaction (defined below; see Note 12) , 15.2 450,000 Promissory Note Conversions During the three months ended March 31, 2021, the holder of a note issued by the Company in June 2020, with an outstanding balance of $ 4.2 million, converted $ 1.0 million of principal and approximately $ 10,000 of accrued interest into 3,365,972 shares of the Company’s common stock. The Company issued the holder an amended and restated promissory note simultaneous with the conversion transaction representing the $ 3.2 million remaining balance due. During 2021, in a series of transactions, the noteholder converted $ 2.8 8,033,296 400,000 During the three months ended March 31, 2022, the noteholder converted the remaining principal balance of $ 400,000 1,142,858 Promissory Notes Issued as Purchase Consideration – Kind Acquisition In connection with the Kind Acquisition (see Note 2), the Company issued four-year promissory notes aggregating $ 6.5 6.0 0.3 1.5 Promissory Notes Issued to Purchase Commercial Vehicles In August 2020, the Company entered into a note agreement with First Citizens’ Federal Credit Union for the purchase of a commercial vehicle (the “First Citizens’ Note”). The First Citizens’ Note bears interest at the rate of 5.74 5,000 In June 2021, the Company entered into a note agreement with Ally Financial for the purchase of a second commercial vehicle (the “Ally Financial Note”). The Ally Financial note bears interest at the rate of 10.0 5,000 Promissory Note Issued by MariMed Hemp Inc. In September 2020, the Company paid $ 0.5 1.0 0.2 0.5 At each of June 30, 2022 and December 31, 2021, the Company was carrying an accrued interest balance of approximately $ 125,000 interest due on this note. Future Payments The future principal amounts due under the Company outstanding mortgages and notes payable at June 30, 2022 are as follows (in thousands): SCHEDULE OF MATURITIES OF OUTSTANDING DEBT Year ending December 31, Remainder of 2022 $ 1,042 2023 2,999 2024 2,323 2025 2,471 2026 1,183 Thereafter 14,025 Total 24,043 Less: discount (680 ) Total debt gross $ 23,363

DEBENTURES PAYABLE

DEBENTURES PAYABLE	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
DEBENTURES PAYABLE	(11) DEBENTURES PAYABLE In a series of transactions from October 2018 through February 2020, the Company sold an aggregate of $ 21.0 As of March 31, 2021, the holder of the $21M Debentures had converted the entire $ 21.0 80.0 1.3 56,000 4,610,645 0.29 52,000 39,000 177,000

MEZZANINE EQUITY

MEZZANINE EQUITY	6 Months Ended
	Jun. 30, 2022
Mezzanine Equity
MEZZANINE EQUITY	(12) MEZZANINE EQUITY Series B Convertible Preferred Stock In 2020, the Company entered into an exchange agreement with two unaffiliated institutional shareholders (the “Exchange Agreement”) whereby the Company (i) issued $ 4.4 4,908,333 In connection with the Exchange Agreement, the Company filed (i) a certificate of designation with respect to the rights and preferences of the Series B Stock, and (ii) a certificate of elimination to return all shares of the Series A convertible preferred stock, of which no shares were issued or outstanding at the time of filing, to the status of authorized and unissued shares of undesignated preferred stock. The holders of Series B Stock (the “Series B Holders”) are entitled to cast the number of votes equal to the number of shares of common stock into which the shares of Series B Stock are convertible, together with the holders of common stock as a single class, on most matters. However, the affirmative vote or consent of the Series B Holders voting separately as a class is required for certain acts taken by the Company, including the amendment or repeal of certain charter provisions, liquidation or winding up of the Company, creation of stock senior to the Series B Stock, and/or other acts defined in the certificate of designation. The Series B Stock shall, with respect to dividend rights and rights on liquidation, winding up and dissolution, rank senior to the Company’s common stock. The Company shall not declare, pay, or set aside any dividends on shares of any other class or series of capital stock of the Company unless the Series B Holders then outstanding shall first receive, or simultaneously receive, a dividend on each outstanding share of Series B Stock in an amount calculated pursuant to the certificate of designation. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holder of Series B Stock shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders before any payment shall be made to the holders of common stock by reason of their ownership thereof, an amount per share of Series B Stock equal to $ 3.00 At any time on or prior to the six-year anniversary of the issuance date of the Series B Stock, (i) the Series B Holders have the option to convert their shares of Series B Stock into common stock at a conversion price of $ 3.00 (ii) the Company has the option to convert all, but not less than all, shares of Series B Stock into common stock at a conversion price of $3.00 if the daily volume weighted average price of common stock (the “VWAP”) exceeds $4.00 per share for at least twenty consecutive trading days prior to the date on which the Company gives notice of such conversion to the Series B Holders. On the day following the six-year anniversary of the issuance of the Series B convertible preferred stock, all outstanding shares of Series B Stock shall automatically convert into common stock as follows: ● If the sixty-day VWAP is less than or equal to $0.50 per share, the Company shall have the option to (i) convert all shares of Series B Stock into common stock at a conversion price of $1.00 per share, and pay cash to the Series B Holders equal to the difference between the sixty-day VWAP and $3.00 per share, or (ii) pay cash to the Series B Holders equal to $3.00 per share. ● If the sixty-day VWAP is greater than $0.50 per share, the Company shall have the option to (i) convert all shares of Series B Stock into common stock at a conversion price per share equal to the quotient of $3.00 per share divided by the sixty-day VWAP, or (ii) pay cash to the Series B Holders equal to $3.00 per share, or (iii) convert all shares of Series B Stock into common stock at a conversion price per share equal to the sixty-day VWAP and pay cash to the Series B Holders equal to the difference between $3.00 per share and the sixty-day VWAP. The Company shall at all times when the Series B Stock is outstanding, reserve and keep available out of its authorized but unissued capital stock, for the purpose of effecting the conversion of the Series B Stock, such number of its duly authorized shares of common stock as shall from time to time be sufficient to effect the conversion of all outstanding Series B Stock. Series C Convertible Preferred Stock In March 2021, the Company entered into a securities purchase agreement with Hadron Healthcare Master Fund (“Hadron”) with respect to a financing facility of up to $ 46.0 At the closing of the Hadron Transaction in March 2021, Hadron purchased $ 23.0 3.70 four-year 6,216,216 15,540,540 1.087 9.5 0.4 In connection with the closing of the Hadron Transaction, the Company filed a certificate of designation with respect to the rights and preferences of the Series C Stock. Such stock is zero coupon, non-voting, and has a liquidation preference equal to its original issuance price plus declared but unpaid dividends. Holders of Series C Stock are entitled to receive dividends on an as-converted basis. Of the $ 23.0 7.3 15.7 No further funding has occurred under the Hadron Facility and, on August 4, 2022, the Company and Hadron entered into a Second Amendment to the Purchase Agreement pursuant to which, inter alia

STOCKHOLDERS_ EQUITY AND STOCK-

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	(13) STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION Common Stock During 2021 and 2022, the Company issued an aggregate of 12,542,126 8.8 1,142,858 During the three months ended June 30, 2022, the Company issued 2,717 2,000 In May 2022, the Company issued 350,000 217,000 In March 2022, the Company issued 375,000 274,000 Amended and Restated 2018 Stock Award and Incentive Plan The Company’s Amended and Restated 2018 Stock Award and Incentive Plan (the “2018 Plan”) provides for the award of options to purchase the Company’s common stock (“stock options”), stock appreciation rights (“SARs”), restricted stock, deferred stock, dividend equivalents, performance shares or other stock-based performance awards and other stock- or cash-based awards. Awards can be granted under the 2018 Plan to the Company’s employees, officers and non-employee directors, as well as consultants and advisors of the Company and its subsidiaries. Warrants At June 30, 2022, warrants to purchase up to 24,676,571 0.89 In April 2022, 750,000 515,039 234,961 Stock Options In June 2022, 312,248 112,248 200,000 At June 30, 2022, options to purchase up to 39,899,423 0.91 four years The grant date fair values of options to purchase common stock granted in the three and six months ended June 30, 2022 were estimated using the Black-Scholes valuation model with the following assumptions: SCHEDULE OF STOCK OPTIONS ESTIMATED USING THE BLACK-SCHOLES VALUATION MODEL WITH ASSUMPTIONS Three months Six months ended ended June 30, June 30, 2022 2022 Estimated life (in years) 5.0 5.0 Volatility 98.4 % 98.4 % Risk-free interest rates 3.0 % 3.0 % Dividend yield - - Stock-Based Compensation The Company recorded stock-based compensation of $ 2.6 5.0 1.2 1.6

REVENUE

REVENUE	6 Months Ended
	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
REVENUE	(14) REVENUE The Company’s main sources of revenue are comprised of the following: ● Product sales (retail and wholesale) – direct sales of cannabis and cannabis-infused products primarily by the Company’s retail dispensaries and wholesale operations in Massachusetts, Illinois and, as of the Kind Acquisition Date, Maryland. This revenue is recognized when products are delivered or at retail points-of-sale. ● Real estate rentals – rental income and additional rental fees generated from leasing of the Company’s state-of-the-art, regulatory compliant cannabis facilities to its cannabis-licensed clients. Rental income is generally a fixed amount per month that escalates over the respective lease terms, while additional rental fees are based on a percentage of tenant revenues that exceed specified amounts. ● Management fees – fees for providing the Company’s cannabis clients with comprehensive oversight of their cannabis cultivation, production and dispensary operations. These fees are based on a percentage of such clients’ revenue and are recognized after services have been performed. ● Supply procurement – resale of cultivation and production resources, supplies and equipment, acquired by the Company from top national vendors at discounted prices, to its clients and third parties within the cannabis industry. The Company recognizes this revenue after the delivery and acceptance of goods by the purchaser. ● Licensing fees – revenue from the sale of the Company’s branded products, including Betty’s Eddies and Kalm Fusion, and from the sublicensing or contracted brands, including Healer and Tikum Olam, to regulated dispensaries throughout the United States and Puerto Rico. This revenue is recognized when the products are delivered. The Financial Accounting Standards Board Accounting Standards Codification 606, Revenue from Contract with Customers, ● Identify the contract(s) with a customer; ● Identify the performance obligations in the contract(s); ● Determine the transaction price; ● Allocate the transaction price to the performance obligations in the contract(s); and ● Recognize revenue as the performance obligation is satisfied. Additionally, when another party is involved in providing goods or services to the Company’s clients, a determination is made as to who—the Company or the other party—is acting in the capacity as the principal in the sale transaction, and who is the agent arranging for goods or services to be provided by the other party. The Company is typically considered the principal if it controls the specified good or service before such good or service is transferred to its client. The Company may also be deemed to be the principal even if it engages another party (an agent) to satisfy some of the performance obligations on its behalf, provided the Company (i) takes on certain responsibilities, obligations, and risks, (ii) possesses certain abilities and discretion, or (iii) other relevant indicators of the sale. If deemed an agent, the Company would not recognize revenue for the performance obligations it does not satisfy. Revenue for the three and six months ended June 30, 2022 and 2021 was comprised of the following (in thousands): SCHEDULE OF REVENUES COMPRISED OF MAJOR CATEGORIES 2022 2021 2022 2021 Three months ended Six months ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 Product revenue: Product sales - retail $ 23,087 $ 20,552 $ 44,528 $ 35,776 Product sales - wholesale 7,958 8,178 14,020 13,903 Total product sales 31,045 28,730 58,548 49,679 Other revenue: Real estate rentals 846 1,862 2,433 3,671 Supply procurement 820 398 2,010 918 Management fees 81 981 834 1,877 Licensing fees 194 598 443 1,067 Total other revenue 1,941 3,839 5,720 7,533 Total revenue $ 32,986 $ 32,569 $ 64,268 $ 57,212

MAJOR CUSTOMERS

MAJOR CUSTOMERS	6 Months Ended
	Jun. 30, 2022
Risks and Uncertainties [Abstract]
MAJOR CUSTOMERS	(15) MAJOR CUSTOMERS The Company did not have any customers that contributed 10 . At June 30, 2022, one customer accounted for 10 26 10 28

LEASES

LEASES	6 Months Ended
	Jun. 30, 2022
Leases
LEASES	(16) LEASES Arrangements that are determined to be leases with a term greater than one year are accounted for by the recognition of right-of-use assets that represent the Company’s right to use an underlying asset for the lease term, and lease liabilities, that represent the Company’s obligation to make lease payments arising from the lease. Non-lease components within lease agreements are accounted for separately. Right-of-use assets and obligations are recognized at the commencement date based on the present value of lease payments over the lease term, utilizing the Company’s incremental borrowing rate. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company is the lessee under six operating leases and four finance leases. These leases contain rent holidays and customary escalations of lease payments for the type of facilities being leased. The Company recognizes rent expense on a straight-line basis over the expected lease term, including cancelable option periods which the Company fully expects to exercise. Certain leases require the payment of property taxes, insurance and/or maintenance costs in addition to the rent payments. The Company leases the following facilities under operating leases: ● Delaware – 4,000 five-year lease that expires in April 2027 ● Delaware – a 100,000 60,000 The lease expires in March 2030, with an option to extend the term for three additional years ● Delaware – a 12,000 The lease expires in January 2026 and contains an option to negotiate an extension at the end of the lease ● Nevada – 10,000 lease expiring in 2024 ● Massachusetts – 10,000 expiring in 2028 option to extend the term for an additional five-year period ● Maryland – a 2,700 expires in July 2023 The Company leases machinery and office equipment under finance leases that expire from February 2024 through February 2026 The components of lease expense for the three and six months ended June 30, 2022 and 2021 were as follows (in thousands): SCHEDULE OF COMPONENTS OF LEASE EXPENSE Three months ended Six months ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 Operating lease expense $ 298 $ 277 $ 575 $ 544 Finance lease expenses: Amortization of right of use assets $ 40 $ 8 $ 59 $ 16 Interest on lease liabilities 10 1 17 3 Total finance lease expense $ 50 $ 9 $ 76 $ 19 At June 30, 2022, the weighted average remaining lease terms for operating leases and finance leases were 6.9 3.5 7.5 12.0 Future minimum lease payments as of June 30, 2022 under all non-cancelable leases having an initial or remaining term of more than one year were (in thousands): SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER ALL NON CANCELABLE OPERATING LEASES Operating Finance leases leases Remainder of 2022 $ 571 $ 90 2023 1,264 176 2024 1,199 153 2025 1,179 150 2026 1,129 22 Thereafter 3,214 - Total lease payments 8,556 591 Less: imputed interest (2,935 ) (73 ) $ 5,621 $ 518 In November 2021, the Company entered into lease agreements for six retail properties, each with square footage between 4,000 6,000 31.00 In the event the Company is awarded one or more of the six Ohio cannabis licenses for which it had previously applied, the Company can extend the term of one or more of the Ohio Leases to ten years (with two additional five-year options to extend) upon the payment of $ 50,000 In February 2022, the Company was notified that it was awarded a cannabis dispensary license from the state of Ohio. The Company is awaiting the final verification process to be completed by the state. As of June 30, 2022, the lease terms of the Ohio Leases were all less than one year, and accordingly the Company has not recorded a right-of-use asset and corresponding lease liability on its balance sheet. In April 2022, the Company extended the term of one of the Ohio Leases, and the remaining five Ohio Leases were terminated.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	(17) RELATED PARTY TRANSACTIONS The Company’s corporate offices are leased from an entity in which the Company’s former Chief Financial Officer, now the Company’s Chief Administrative Officer (“CAO”) has an investment interest. This lease expires in October 2028 and contains a five-year extension option. Expenses incurred under this lease were approximately $ 39,000 78,000 The Company procures nutrients, lab equipment, cultivation supplies, furniture, and tools from an entity owned by the family of the Company’s Chief Operating Officer (“COO”). Purchases from this entity totaled $ 1.4 2.3 1.2 2.0 The Company pays royalties on the revenue generated from its Betty’s Eddies product line to an entity owned by the Company’s COO and its Senior Vice President of Sales (“SVP Sales”) under a royalty agreement. This agreement was amended effective January 1, 2021 whereby, among other modifications, the royalty percentage changed from 2.5% on all sales of Betty’s Eddies products to (i) 3.0% and 10.0% of wholesale sales of existing products within the product line if sold directly by the Company, or licensed by the Company for sale by third parties, respectively, and (ii) 0.5% and 1.0% of wholesale sales of future developed products within the product line if sold directly by the Company, or licensed by the Company for sale by third-parties, respectively 53,000 109,000 79,000 162,000 During the three and six months ended June 30, 2022, one of the Company’s majority-owned subsidiaries paid aggregate distributions of $ 12,600 23,100 12,000 21,000 During the three and six months ended June 30, 2022, one of the Company’s majority-owned subsidiaries paid distributions of $ 8,000 11,000 During the three and six months ended June 30, 2022, the Company purchased fixed assets and consulting services aggregating $ 267,000 659,000 308,000 573,000 During the three and six months ended June 30, 2022, the Company purchased fixed assets of $ 278,000 360,000 156,000 466,000 The Company’s mortgages with Bank of New England, DuQuoin State Bank, and South Porte Bank are personally guaranteed by the Company’s CEO and the Company’s CAO.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	(18) COMMITMENTS AND CONTINGENCIES Maryland Litigation Following the consummation of the Kind Acquisition, in April 2022, the Maryland litigation between the Company and the members of Kind was dismissed in its entirety with prejudice, and the parties have released one another of any and all claims between them. DiPietro Lawsuit In December 2021, the parties to this action entered into a global confidential settlement and release agreement, along with the parties to the aforementioned Maryland litigation. At the same date, the Company’s wholly-owned subsidiary MariMed Advisors Inc. (“MMA”) and Jennifer DiPietro (“Ms. DiPietro”), one of the former members of Kind, entered into membership interest purchase agreement pursuant to which the Company would purchase Ms. DiPietro’s interests in Mia and Mari-MD. Upon the court’s approval of the parties’ joint motion for approval, on June 8, 2022, the purchase of Ms. DiPietro’s interests was consummated. The parties released all direct and derivative claims against one another, and a stipulation dismissing all claims and counterclaims with prejudice was filed with the court. Bankruptcy Claim During 2019, the Company’s MMH subsidiary sold and delivered hemp seed inventory to GenCanna Global Inc., a Kentucky-based cultivator, producer, and distributor of hemp (“GenCanna”). At the time of sale, the Company owned a 33.5 29.0 In February 2020, GenCanna USA, GenCanna’s wholly-owned operating subsidiary, under pressure from certain of its creditors including MGG Investment Group LP, GenCanna’s senior lender (“MGG”), agreed to convert a previously-filed involuntary bankruptcy proceeding with the U.S. Bankruptcy Court in the Eastern District of Kentucky (the “Bankruptcy Court”) into a voluntary Chapter 11 proceeding. In addition, GenCanna and GenCanna USA’s subsidiary, Hemp Kentucky LLC (collectively with GenCanna and GenCanna USA, the “GenCanna Debtors”), filed voluntary petitions under Chapter 11 in the Bankruptcy Court. In May 2020, after an abbreviated solicitation/bid/sale process, the Bankruptcy Court, over numerous objections by creditors and shareholders of the GenCanna Debtors which included the Company, entered an order authorizing the sale of all or substantially all of the assets of the GenCanna Debtors to MGG. After the consummation of the sale of all or substantially all of their assets and business, the GenCanna Debtors n/k/a OGGUSA, Inc. and OGG, Inc. (the “OGGUSA Debtors”) filed their liquidating plan of reorganization (the “Liquidating Plan”) to collect various prepetition payments and commercial claims against third parties, liquidate the remaining assets of the ODDUSA Debtors, and make payments to creditors. The Company and the unsecured creditors committee filed objections to such Liquidating Plan, including opposition to the release of litigation against the OGGUSA Debtors’ senior lender, MGG, for lender liability, equitable subordination, and return of preference. As a part of such plan confirmation process, the OGGUSA Debtors filed various objections to proofs of claims filed by various creditors, including the proof of claim in the amount of $ 33.6 31.0 Since the approval of the Liquidating Plan, the OGGUSA Debtors have been in the process of liquidating the remaining assets, negotiating and prosecuting objections to other creditors’ claims, and pursuing the collection of accounts receivable and Chapter 5 bankruptcy avoidance claims. In January 2022, the Company, at the request of the Liquidating Plan administrator for the OGGUSA Debtors, executed a written release of claims, if any, of the Company against Huron Consulting Group (“Huron”), a financial consulting and management company retained by the senior lender of the OGGUSA Debtors to perform loan management services for the lender and OGGUSA Debtors prior to and during their Chapter 11 bankruptcy cases. Such release was executed in connection with a comprehensive settlement agreement between the OGGUSA Debtors and Huron. In consideration for the Company’s execution of the release, Huron paid an additional $ 40,000 On April 20, 2022, the Plan Administrator for the OGGUSA Debtors filed an adversary proceeding against the Company seeking to recover approximately $ 200,000 As of the date of this filing, there is still insufficient information as to what portion, if any, of the Company’s allowed claim will be paid upon the completion of the liquidation of the remaining assets of the OGGUSA Debtors.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(19) SUBSEQUENT EVENTS The Company’s common stock commenced trading on the Canadian Securities Exchange on July 12, 2022 under the ticker symbol MRMD. In July 2022, Mari Holdings Mt Vernon LLC, a wholly owned subsidiary of the Company, entered into a $ 3 20 7.75 7.75

BASIS OF PRESENTATION (Policies

BASIS OF PRESENTATION (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Business	Business MariMed Inc. (“MariMed” or the “Company”) is a multi-state operator in the United States cannabis industry. MariMed develops, operates, manages, and optimizes over 300,000
Basis of Presentation	Basis of Presentation In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in accordance with accounting principles generally accepted in the United States of America (“GAAP”). On April 27, 2022 (the “Kind Acquisition Date”), the Company acquired Kind Therapeutics USA (“Kind”). The financial results of Kind are included in the Company’s condensed consolidated financial statements for the period subsequent to the Kind Acquisition Date. Interim results are not necessarily indicative of results for the full fiscal year or any future interim period. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “Annual Report”), which was filed with the U.S. Securities and Exchange Commission (“SEC”) on March 16, 2022. Certain reclassifications, not affecting previously reported net income or cash flows, have been made to the previously issued financial statements to conform to the current period presentation.
Significant Accounting Policies	Significant Accounting Policies The Company’s significant accounting policies are disclosed in Note 2 to the Consolidated Financial Statements included in the Annual Report. There were no material changes to the significant accounting policies during the three- or six-month periods ended June 30, 2022.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of MariMed and its wholly- and majority-owned subsidiaries. Intercompany transactions and balances have been eliminated in consolidation. Noncontrolling interests represent third-party minority ownership interests in the Company’s majority-owned consolidated subsidiaries. Net income attributable to noncontrolling interests is reported in the condensed consolidated statements of operations, and the value of minority-owned interests are presented as a component of equity within the condensed consolidated balance sheets.
Use of Estimates and Judgments	Use of Estimates and Judgments The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenue and expenses during the reporting periods. Significant estimates and judgments relied upon in preparing these condensed consolidated financial statements include accounting for business combinations, inventory valuations, assumptions used to determine the fair value of stock-based compensation, and intangible asset and goodwill. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity date of three months or less to be cash equivalents. The fair values of these investments approximate their carrying values. At June 30, 2022 and December 31, 2021, the Company had cash of $ 0.1 5.1 5.0
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts of the Company’s financial instruments approximate their fair values and include cash equivalents, accounts receivable, deferred rents receivable, notes receivable, mortgages and notes payable, and accounts payable. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The three-tier fair value hierarchy is based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Level 2 Level 3
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, Accounting Standards Updates (“ASUs”) and does not believe that the future adoption of any such ASUs will have a material impact on its financial condition or results of operations.

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	6 Months Ended
	Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]
SCHEDULE OF ACQUIRED ASSETS IDENTIFIABLE INTANGIBLE ASSETS AND CERTAIN ASSUMED LIABILITIES	A summary of the preliminary allocation of Kind Consideration to the acquired assets, identifiable intangible assets and certain assumed liabilities is as follows (in thousands): SCHEDULE OF ACQUIRED ASSETS IDENTIFIABLE INTANGIBLE ASSETS AND CERTAIN ASSUMED LIABILITIES Fair value of consideration transferred: Cash consideration: Cash paid at closing $ 10,128 Release of escrow 2,444 Severance paid from escrow 556 Less cash acquired (2,310 ) Net cash consideration 10,818 Note payable 5,634 Write-off accounts receivable 658 Write-off of deferred accounts receivable 842 Total fair value of consideration transferred $ 17,952 Fair value of assets acquired and (liabilities assumed): Current assets, net of cash acquired $ 5,047 Property and equipment 622 Intangible assets: Tradename and trademarks 2,041 Licenses and customer base 4,700 Non-compete agreements 42 Goodwill 6,011 Current liabilities (511 ) Total fair value of assets acquired and (liabilities assumed) $ 17,952

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	6 Months Ended
	Jun. 30, 2022
Net income per share attributable to common stockholders:
SCHEDULE OF EARNINGS PER SHARE	The calculations of shares used to compute net earnings per share were as follows (in thousands): SCHEDULE OF EARNINGS PER SHARE 2022 2021 2022 2021 Three months ended Six months ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 Weighted average shares outstanding - basic 337,497 324,267 336,137 321,741 Potential dilutive common shares 42,129 45,990 43,088 43,583 Weighted average shares outstanding - diluted 379,626 370,257 379,225 365,324

DEFERRED RENTS RECEIVABLE (Tabl

DEFERRED RENTS RECEIVABLE (Tables)	6 Months Ended
	Jun. 30, 2022
Deferred Rents Receivable
SCHEDULE OF FUTURE MINIMUM RENTAL RECEIPTS FOR NON-CANCELABLE LEASES AND SUBLEASES	Future minimum rental receipts for non-cancellable leases and subleases as of June 30, 2022 were as follows (in thousands): SCHEDULE OF FUTURE MINIMUM RENTAL RECEIPTS FOR NON-CANCELABLE LEASES AND SUBLEASES Year ending December 31, Remainder of 2022 $ 1,085 2023 1,911 2024 1,925 2025 1,946 2026 1,868 Thereafter 11,366 Total $ 20,101

NOTES RECEIVABLE (Tables)

NOTES RECEIVABLE (Tables)	6 Months Ended
	Jun. 30, 2022
Receivables [Abstract]
SCHEDULE OF NOTES RECEIVABLES	Notes receivable, including accrued interest, at June 30, 2022 and December 31, 2021 consisted of the following (in thousands): SCHEDULE OF NOTES RECEIVABLES June 30, December 31, First State Compassion Center (initial note) $ 367 $ 403 First State Compassion Center (secondary note) 8,002 7,845 Healer LLC 879 866 Total notes receivable 9,248 9,114 Notes receivable, current portion 132 127 Notes receivable, less current portion $ 9,116 $ 8,987

INVENTORY (Tables)

INVENTORY (Tables)	6 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORY	Inventory at June 30, 2022 and December 31, 2021 consisted of the following (in thousands): SCHEDULE OF INVENTORY June 30, December 31, Plants $ 1,430 $ 1,015 Ingredients and other raw materials 498 262 Work-in-process 8,262 4,661 Finished goods 5,699 3,830 Total inventory $ 15,889 $ 9,768

INVESTMENTS (Tables)

INVESTMENTS (Tables)	6 Months Ended
	Jun. 30, 2022
Schedule of Investments [Abstract]
SCHEDULE OF INVESTMENTS	The Company’s investments at June 30, 2022 and December 31, 2021 were comprised of the following (in thousands): SCHEDULE OF INVESTMENTS June 30, December 31, Investments – current: Flowr Corp. (formerly Terrace Inc.) $ 124 $ 251 WM Technology Inc. 401 - Total current investments $ 525 $ 251

PROPERTY AND EQUIPMENT, NET (Ta

PROPERTY AND EQUIPMENT, NET (Tables)	6 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	The Company’s property and equipment, net, at June 30, 2022 and December 31, 2021 was comprised of the following (in thousands): SCHEDULE OF PROPERTY AND EQUIPMENT June 30, December 31, Land $ 4,450 $ 4,450 Buildings and building improvements 38,672 35,231 Tenant improvements 16,990 9,745 Furniture and fixtures 1,973 1,888 Machinery and equipment 9,466 7,221 Construction in progress 5,897 10,569 Property and equipment, gross 77,448 69,104 Less: accumulated depreciation (8,316 ) (6,954 ) Property and equipment, net $ 69,132 $ 62,150

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL (Tables)	6 Months Ended
	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
SCHEDULE OF ACQUIRED INTANGIBLE ASSETS	The Company’s acquired intangible assets at June 30, 2022 consisted of the following (in thousands): SCHEDULE OF ACQUIRED INTANGIBLE ASSETS Weighted average Net amortization Accumulated carrying period (years) Cost amortization value Tradename and trademarks 3.00 $ 2,041 $ 113 $ 1,928 Licenses and customer base 8.26 8,100 169 7,931 Non-compete agreements 2.00 42 3 39 7.18 $ 10,183 $ 285 $ 9,898
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE OF INTANGIBLE ASSETS	Estimated future amortization expense for the Company’s intangible assets at June 30, 2022 was as follows: SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE OF INTANGIBLE ASSETS Year ending December 31, Remainder of 2022 $ 856 2023 1,712 2024 1,699 2025 1,239 2026 1,011 Thereafter 3,381 Total $ 9,898
SCHEDULE OF GOODWILL	The changes in the carrying value of the Company’s goodwill in the three months ended June 30, 2022 and 2021 were as follows (in thousands): SCHEDULE OF GOODWILL 2022 2021 Balance at January 1, $ 2,068 $ 2,068 Kind Acquisition 6,011 - Balance at June 30, $ 8,079 $ 2,068

MORTGAGES AND NOTES PAYABLE (Ta

MORTGAGES AND NOTES PAYABLE (Tables)	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
SCHEDULE OF MORTGAGES	The Company’s mortgage balances, including accrued interest, at June 30, 2022 and December 31, 2021 were comprised of the following (in thousands): SCHEDULE OF MORTGAGES June 30, December 31, Bank of New England – New Bedford, MA and Middleboro, MA properties $ 12,319 $ 12,499 Bank of New England – Wilmington, DE property 1,404 1,463 DuQuoin State Bank – Anna, IL and Harrisburg, IL properties 767 778 DuQuoin State Bank – Metropolis, IL property 2,574 2,658 South Porte Bank – Mt. Vernon, IL property 814 816 Total mortgages payable 17,878 18,214 Less: Mortgages payable, current ( 1,417 ) ( 1,400 ) Mortgages payable, less current portion $ 16,461 $ 16,814
SCHEDULE OF MATURITIES OF OUTSTANDING DEBT	The future principal amounts due under the Company outstanding mortgages and notes payable at June 30, 2022 are as follows (in thousands): SCHEDULE OF MATURITIES OF OUTSTANDING DEBT Year ending December 31, Remainder of 2022 $ 1,042 2023 2,999 2024 2,323 2025 2,471 2026 1,183 Thereafter 14,025 Total 24,043 Less: discount (680 ) Total debt gross $ 23,363

STOCKHOLDERS_ EQUITY AND STOC_2

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
SCHEDULE OF STOCK OPTIONS ESTIMATED USING THE BLACK-SCHOLES VALUATION MODEL WITH ASSUMPTIONS	The grant date fair values of options to purchase common stock granted in the three and six months ended June 30, 2022 were estimated using the Black-Scholes valuation model with the following assumptions: SCHEDULE OF STOCK OPTIONS ESTIMATED USING THE BLACK-SCHOLES VALUATION MODEL WITH ASSUMPTIONS Three months Six months ended ended June 30, June 30, 2022 2022 Estimated life (in years) 5.0 5.0 Volatility 98.4 % 98.4 % Risk-free interest rates 3.0 % 3.0 % Dividend yield - -

REVENUE (Tables)

REVENUE (Tables)	6 Months Ended
	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
SCHEDULE OF REVENUES COMPRISED OF MAJOR CATEGORIES	Revenue for the three and six months ended June 30, 2022 and 2021 was comprised of the following (in thousands): SCHEDULE OF REVENUES COMPRISED OF MAJOR CATEGORIES 2022 2021 2022 2021 Three months ended Six months ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 Product revenue: Product sales - retail $ 23,087 $ 20,552 $ 44,528 $ 35,776 Product sales - wholesale 7,958 8,178 14,020 13,903 Total product sales 31,045 28,730 58,548 49,679 Other revenue: Real estate rentals 846 1,862 2,433 3,671 Supply procurement 820 398 2,010 918 Management fees 81 981 834 1,877 Licensing fees 194 598 443 1,067 Total other revenue 1,941 3,839 5,720 7,533 Total revenue $ 32,986 $ 32,569 $ 64,268 $ 57,212

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Jun. 30, 2022
Leases
SCHEDULE OF COMPONENTS OF LEASE EXPENSE	The components of lease expense for the three and six months ended June 30, 2022 and 2021 were as follows (in thousands): SCHEDULE OF COMPONENTS OF LEASE EXPENSE Three months ended Six months ended June 30, June 30, June 30, June 30, 2022 2021 2022 2021 Operating lease expense $ 298 $ 277 $ 575 $ 544 Finance lease expenses: Amortization of right of use assets $ 40 $ 8 $ 59 $ 16 Interest on lease liabilities 10 1 17 3 Total finance lease expense $ 50 $ 9 $ 76 $ 19
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER ALL NON CANCELABLE OPERATING LEASES	Future minimum lease payments as of June 30, 2022 under all non-cancelable leases having an initial or remaining term of more than one year were (in thousands): SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER ALL NON CANCELABLE OPERATING LEASES Operating Finance leases leases Remainder of 2022 $ 571 $ 90 2023 1,264 176 2024 1,199 153 2025 1,179 150 2026 1,129 22 Thereafter 3,214 - Total lease payments 8,556 591 Less: imputed interest (2,935 ) (73 ) $ 5,621 $ 518

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Narrative) $ in Millions	Jun. 30, 2022 USD ($)	Apr. 30, 2022 ft²	Dec. 31, 2021 USD ($)	Jun. 30, 2021 ft²
Accounting Policies [Abstract]
Area of land | ft²		14,000		300,000
Cash	$ 0.1		$ 0.1
Cash hled in escrow	$ 5.1		5.1
Escrow deposit			$ 5

SCHEDULE OF ACQUIRED ASSETS IDE

SCHEDULE OF ACQUIRED ASSETS IDENTIFIABLE INTANGIBLE ASSETS AND CERTAIN ASSUMED LIABILITIES (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Fair value of assets acquired and (liabilities assumed):
Goodwill	$ 8,079	$ 2,068	$ 2,068	$ 2,068
Kind Therapeutics USA LLC. [Member]
Fair value of consideration transferred:
Cash paid at closing	10,128
Release of escrow	2,444
Severance paid from escrow	556
Less cash acquired	(2,310)
Net cash consideration	10,818
Note payable	5,634
Write-off accounts receivable	658
Write-off of deferred accounts receivable	842
Total fair value of consideration transferred	17,952
Fair value of assets acquired and (liabilities assumed):
Current assets, net of cash acquired	5,047
Property and equipment	622
Goodwill	6,011
Current liabilities	(511)
Total fair value of assets acquired and (liabilities assumed)	17,952
Kind Therapeutics USA LLC. [Member] | Trademarks and Trade Names [Member]
Fair value of assets acquired and (liabilities assumed):
Non-compete agreements	2,041
Kind Therapeutics USA LLC. [Member] | Licenses and Customer Base [Member]
Fair value of assets acquired and (liabilities assumed):
Non-compete agreements	4,700
Kind Therapeutics USA LLC. [Member] | Noncompete Agreements [Member]
Fair value of assets acquired and (liabilities assumed):
Non-compete agreements	$ 42

ACQUISITIONS (Details Narrative

ACQUISITIONS (Details Narrative)			1 Months Ended			6 Months Ended		12 Months Ended
	May 05, 2022 USD ($) shares	Apr. 13, 2022 USD ($)	Jan. 31, 2022 USD ($)	Nov. 30, 2021 USD ($) shares	Sep. 30, 2021 USD ($) shares	Jun. 30, 2022 USD ($) shares	Jun. 30, 2021 USD ($) ft²	Dec. 31, 2021 USD ($)	Dec. 31, 2019 USD ($) shares	Apr. 30, 2022 ft² shares
Business Acquisition [Line Items]
Intangible assets useful lives						7 years 2 months 4 days
Common stock value,issued						$ 339,000		$ 334,000
Produce cannabis | ft²							300,000			14,000
Amortization expense of intangible asset						$ 425,000	$ 346,000
Warrants to purchase shares | shares						24,676,571				750,000
Beverly Asset Purchase [Member]
Business Acquisition [Line Items]
Stock issued during period shares purchase of assets | shares				2,000,000
Stock issued during period value purchase of assets				$ 5,100,000
Green Growth Group Inc Member]
Business Acquisition [Line Items]
Payments to acquire management contract rights			$ 1,900,000
Common stock value,issued			1,500,000
Business combination contingent consideration liability			$ 100,000
Payments to acquire business comibination	$ 1,800,000
Payments to acquire management contract rights | shares	2,343,750
Amortization expense of intangible asset						$ 57,000
Meditaurus LLC [Member]
Business Acquisition [Line Items]
Common stock value,issued					$ 94,000
Sale of stock, shares | shares					100,000
Cash acquired from acquisition					$ 10,000
Net of cash acquired									$ 2,800,000
Noncontrolling interest increase from business combination					$ 975,000
The Harvest Foundation LLC [Member]
Business Acquisition [Line Items]
Sale of stock, shares | shares									1,000,000
Percentage of voting interests acquired									100%
Sale of stock, value									$ 1,200,000
Warrants to purchase shares | shares									400,000
Mari Holdings MD LLC [Member]
Business Acquisition [Line Items]
Increase in ownership percentage						99.70%
Mia Development LLC [Member]
Business Acquisition [Line Items]
Increase in ownership percentage						94.30%
Mari-MD and Mia [Member]
Business Acquisition [Line Items]
Aggregate purchase consideration paid		$ 2,000,000
Kind Therapeutics USA LLC. [Member]
Business Acquisition [Line Items]
Ownership percentage								100%
Payments to acquire management contract rights								$ 13,500,000
Escrow deposit disbursements related to property acquisition								5,000,000
Business acquisitions, revenue								1,700,000
Business acquisitions related net loss								300,000
Intangible assets useful lives						5 years 9 months 7 days
Kind Therapeutics USA LLC. [Member] | 6% Promissory notes [Member]
Business Acquisition [Line Items]
Line of credit facility, current borrowing capacity								$ 6,500,000
Green Growth Group Inc Member]
Business Acquisition [Line Items]
Ownership percentage			100%
Meditaurus LLC [Member]
Business Acquisition [Line Items]
Ownership percentage					30%				70%

SCHEDULE OF EARNINGS PER SHARE

SCHEDULE OF EARNINGS PER SHARE (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net income per share attributable to common stockholders:
Weighted average shares outstanding - basic	337,497	324,267	336,137	321,741
Potential dilutive common shares	42,129	45,990	43,088	43,583
Weighted average shares outstanding - diluted	379,626	370,257	379,225	365,324

SCHEDULE OF FUTURE MINIMUM RENT

SCHEDULE OF FUTURE MINIMUM RENTAL RECEIPTS FOR NON-CANCELABLE LEASES AND SUBLEASES (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Deferred Rents Receivable
Remainder of 2022	$ 1,085
2023	1,911
2024	1,925
2025	1,946
2026	1,868
Thereafter	11,366
Total	$ 20,101

DEFERRED RENTS RECEIVABLE (Deta

DEFERRED RENTS RECEIVABLE (Details Narrative) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($) ft²	Jun. 30, 2021 USD ($) ft²	Jun. 30, 2022 USD ($) ft²	Jun. 30, 2021 USD ($) ft²	Apr. 30, 2022 ft²
Area of land		300,000		300,000	14,000
Rental payments | $	$ 0.8	$ 1.2	$ 2	$ 2.4
Revenue recognization | $	$ 0.8	$ 1.1	$ 1.9	$ 2.3
DELAWARE
Area of land	45,000		45,000
Lease expiration description			expires in 2035
DELAWARE | Cannabis Dispensary [Member]
Area of land	4,000		4,000
Lease expiration description			expiring in April 2027
DELAWARE | Warehouse [Member]
Area of land	100,000		100,000
DELAWARE | Cultivation and Processing Facility [Member]
Area of land	60,000		60,000
Lease expiration description			The sublease expires in March 2030, with an option to extend the term for three additional five-year periods.
DELAWARE | Cannabis Production Facility [Member]
Area of land	12,000		12,000
Lease expiration description			The sublease expires in January 2026 and contains an option to negotiate an extension at the end of the lease term.
MARYLAND
Area of land	180,000		180,000
Lease expiration description			expires in 2037
MASSACHUSETTS
Area of land	138,000		138,000
Lease expiration description			October 2022

SCHEDULE OF NOTES RECEIVABLES (

SCHEDULE OF NOTES RECEIVABLES (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Total notes receivable	$ 9,248	$ 9,114
Notes receivable, current portion	132	127
Notes receivable, less current portion	9,116	8,987
First State Compassion Center [Member]
Total notes receivable	367	403
First State Compassion Center Secondary Note [Member]
Total notes receivable	8,002	7,845
Healer LLC [Member]
Total notes receivable	$ 879	$ 866

NOTES RECEIVABLE (Details Narra

NOTES RECEIVABLE (Details Narrative) - USD ($)	1 Months Ended			6 Months Ended
	Aug. 31, 2021	Mar. 31, 2021	May 31, 2016	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Proceeds from sale of notes receivable					$ 119,000
Notes receivable related parties current				132,000		$ 127,000
Notes receivable				9,248,000		$ 9,114,000
Principal balance				8,800,000
First State Compassion Center [Member] | Convertible Promissory Note [Member]
Defined Benefit Plan Disclosure [Line Items]
Loan interest rate						6%
Notes receivable						$ 7,800,000
Convertible note payable						7,800,000
Interest receivable					$ 54,000
First State Compassion Center [Member]
Defined Benefit Plan Disclosure [Line Items]
Debt instrument term			10 years
Proceeds from sale of notes receivable			$ 700,000
Loan interest rate			12.50%
Debt instrument periodic payment			$ 10,000
Notes receivable related parties current				80,000		75,000
Healer LLC [Member]
Defined Benefit Plan Disclosure [Line Items]
Loan interest rate		6%
Interest receivable		$ 94,000
Principal balance		800,000
Licensing fees		28,000
Healer LLC [Member] | Promissory Note [Member]
Defined Benefit Plan Disclosure [Line Items]
Principal balance		900,000
Healer LLC [Member] | Revised Healer Note [Member]
Defined Benefit Plan Disclosure [Line Items]
Principal balance		$ 866,000		$ 52,000		$ 52,000
High Fidelity Inc [Member]
Defined Benefit Plan Disclosure [Line Items]
Loan interest rate	10%
Amount of loans to related party	$ 250,000

SCHEDULE OF INVENTORY (Details)

SCHEDULE OF INVENTORY (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Plants	$ 1,430	$ 1,015
Ingredients and other raw materials	498	262
Work-in-process	8,262	4,661
Finished goods	5,699	3,830
Total inventory	$ 15,889	$ 9,768

SCHEDULE OF INVESTMENTS (Detail

SCHEDULE OF INVESTMENTS (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Schedule of Investments [Line Items]
Total current investments	$ 525	$ 251
Terrace Inc [Member]
Schedule of Investments [Line Items]
Total current investments	124	251
WM Technology Inc [Member]
Schedule of Investments [Line Items]
Total current investments	$ 401

INVESTMENTS (Details Narrative)

INVESTMENTS (Details Narrative) - USD ($)	1 Months Ended				3 Months Ended		6 Months Ended
	Feb. 28, 2022	Sep. 30, 2021	Jan. 31, 2021	Dec. 31, 2020	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Restructuring Cost and Reserve [Line Items]
Noncurrent investment					$ 0		$ 0
Gain (loss) on investments							(679,000)	$ (415,000)
MembersRSVP LLC [Member]
Restructuring Cost and Reserve [Line Items]
Ownership percentage by parent			12%
Membership interest transferred			11%
Proceeds from investment		$ 1,500,000
Gain loss on sale of investment		$ 300,000			600,000		600,000
Stock issued during period shares purchase of assets	121,968
MembersRSVP LLC [Member] | Membership Interest Agreement [Member]
Restructuring Cost and Reserve [Line Items]
Ownership percentage by parent			23%
Terrace Inc [Member]
Restructuring Cost and Reserve [Line Items]
Percentage for acquired interest rate				8.95%
Number of shares received under acquisition				0.4973
Gain (loss) on investments					$ 200,000	$ 400,000	$ 100,000	$ 400,000

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 77,448	$ 69,104
Less: accumulated depreciation	(8,316)	(6,954)
Property and equipment, net	69,132	62,150
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	4,450	4,450
Buildings and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	38,672	35,231
Tenant Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	16,990	9,745
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,973	1,888
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	9,466	7,221
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 5,897	$ 10,569

SCHEDULE OF ACQUIRED INTANGIBLE

SCHEDULE OF ACQUIRED INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period	7 years 2 months 4 days
Cost	$ 10,183
Accumulated amortization	285
Intangible assets net	$ 9,898	$ 162
Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period	3 years
Cost	$ 2,041
Accumulated amortization	113
Intangible assets net	$ 1,928
Licenses and Customer Base [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period	8 years 3 months 3 days
Cost	$ 8,100
Accumulated amortization	169
Intangible assets net	$ 7,931
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted average amortization period	2 years
Cost	$ 42
Accumulated amortization	3
Intangible assets net	$ 39

SCHEDULE OF ESTIMATED FUTURE AM

SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE OF INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2022	$ 856
2023	1,712
2024	1,699
2025	1,239
2026	1,011
Thereafter	3,381
Total	$ 9,898	$ 162

SCHEDULE OF GOODWILL (Details)

SCHEDULE OF GOODWILL (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Balance at January 1,	$ 2,068	$ 2,068
Kind Acquisition	6,011
Balance at June 30,	$ 8,079	$ 2,068

SCHEDULE OF MORTGAGES (Details)

SCHEDULE OF MORTGAGES (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Total mortgages payable	$ 24,043
Mortgage [Member]
Short-Term Debt [Line Items]
Total mortgages payable	17,878	$ 18,214
Less: Mortgages payable, current	1,417	1,400
Mortgages payable, less current portion	16,461	16,814
Mortgage [Member] | Bank of New England - New Bedford, MA and Middleboro, MA properties [Member]
Short-Term Debt [Line Items]
Total mortgages payable	12,319	12,499
Mortgage [Member] | Bank of New England - Wilmington, DE property [Member]
Short-Term Debt [Line Items]
Total mortgages payable	1,404	1,463
Mortgage [Member] | DuQuoin State Bank - Anna, IL and Harrisburg, IL properties [Member]
Short-Term Debt [Line Items]
Total mortgages payable	767	778
Mortgage [Member] | DuQuoin State Bank - Metropolis, IL property [Member]
Short-Term Debt [Line Items]
Total mortgages payable	2,574	2,658
Mortgage [Member] | South Porte Bank - Mt. Vernon, IL property [Member]
Short-Term Debt [Line Items]
Total mortgages payable	$ 814	$ 816

SCHEDULE OF MATURITIES OF OUTST

SCHEDULE OF MATURITIES OF OUTSTANDING DEBT (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Debt Disclosure [Abstract]
Remainder of 2022	$ 1,042
2023	2,999
2024	2,323
2025	2,471
2026	1,183
Thereafter	14,025
Total	24,043
Less: discount	(680)
Total debt gross	$ 23,363

MORTGAGES AND NOTES PAYABLE (De

MORTGAGES AND NOTES PAYABLE (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Jul. 31, 2021

Jun. 30, 2021

May 31, 2021

Mar. 31, 2021

Sep. 30, 2020

Aug. 31, 2020

Feb. 29, 2020

Mar. 31, 2022

Mar. 31, 2021

Jun. 30, 2022

Jun. 30, 2021

Dec. 31, 2021

Short-Term Debt [Line Items]

Proceeds from notes payable

$ 35,000

Debt instrument, face amount

24,043,000

Debt instrument face amount

8,800,000

Fully amortized debt discount

$ 52,000

Debt instrument, converted principal amount

$ 400,000

Debt instrument converted, shares issued

12,542,126

12,542,126

MariMed Hemp Inc. [Member]

Short-Term Debt [Line Items]

Debt instrument face amount

$ 1,000,000

Repayments of notes payable

$ 500,000

$ 500,000

Interest expense debt

200,000

Accrued interest

$ 125,000

Mezzanine Equity [Member]

Short-Term Debt [Line Items]

Debt instrument face amount

15,200,000

$ 15,200,000

Fully amortized debt discount

450,000

June 2020 Promissory Note Conversion [Member]

Short-Term Debt [Line Items]

Debt instrument face amount

4,200,000

$ 400,000

4,200,000

$ 400,000

Debt instrument, converted principal amount

1,000,000

$ 2,800,000

Debt conversion accrued interest

$ 10,000

Debt instrument converted, shares issued

1,142,858

3,365,972

8,033,296

Amended and Restated Promissory Note Conversion [Member]

Short-Term Debt [Line Items]

Debt instrument face amount

$ 3,200,000

$ 3,200,000

Mortgage Agreement [Member] | DuQuoin State Bank [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

6.75%

Debt principal amount, current

$ 32,000

$ 33,000

Mortgage Agreement [Member] | South Porte Bank [Member]

Short-Term Debt [Line Items]

Debt instrument periodic payment

$ 6,000

Kind Acquisition [Member] | Promissory Notes [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

6%

Debt instrument face amount

$ 6,500,000

Notes payable

300,000

Notes payable, current

1,500,000

First Citizens Federal Credit Union [Member] | Promissory Notes [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

5.74%

Notes payable, current

5,000

5,000

Note Agreement [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

10%

Notes payable, current

$ 5,000

5,000

New Bedford, MA and Middleboro, MA [Member] | Mortgage Agreement [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

6.50%

Debt instrument, maturity

August 2025

Proceeds from notes payable

$ 4,800,000

Debt principal amount, current

370,000

358,000

New Bedford, MA and Middleboro, MA [Member] | Mortgage Agreement [Member] | Promissory Note [Member]

Short-Term Debt [Line Items]

Proceeds from notes payable

$ 7,200,000

DELAWARE | Mortgage Agreement [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

5.25%

Debt instrument, maturity

The mortgage matures in 2031

Debt principal amount, current

$ 123,000

120,000

DELAWARE | Mortgage Agreement [Member] | Prime Rate [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

1.50%

DELAWARE | Mortgage Agreement [Member] | Floor Rate [Member]

Short-Term Debt [Line Items]

Note bears interest rate during period

5.25%

Metropolis [Member] | Second Mortgage Agreement [Member]

Short-Term Debt [Line Items]

Percentage Owned

70%

Metropolis [Member] | Mortgage Agreement [Member]

Short-Term Debt [Line Items]

Debt principal amount, current

$ 78,000

$ 73,000

Stock issued during period, shares, purchase of assets

750,000

Stock issued during period, shares, purchase of assets

$ 705,000

Debt instrument, face amount

$ 1,600,000

Metropolis [Member] | Second Mortgage Agreement [Member]

Short-Term Debt [Line Items]

Debt instrument, maturity

matures in July 2041

Debt instrument, face amount

$ 2,700,000

Debt instrument, basis spread on variable rate

6.25%

Metropolis [Member] | Second Mortgage Agreement [Member] | Mari Holdings Metropolics LLC [Member]

Short-Term Debt [Line Items]

Percentage Owned

30%

DEBENTURES PAYABLE (Details Nar

DEBENTURES PAYABLE (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Feb. 29, 2020
Short-Term Debt [Line Items]
Debt instrument, face amount		$ 8,800,000
Debt instrument converted, shares issued		12,542,126	12,542,126
Amortization of debt discount premium			$ 52,000
21M Convertible Debentures [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount	$ 1,300,000			$ 21,000,000
Debt instrument, unamortized discount	52,000
Amortization of debt discount premium	39,000
Debt instrument, convertible, beneficial conversion feature	177,000
21M Convertible Debentures [Member] | Holder [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount	$ 21,000,000
Debt conversion converted instrument rate	80%
Interest payable	$ 56,000
Debt instrument converted, shares issued	4,610,645
Debt instrument convertible conversion price	$ 0.29

MEZZANINE EQUITY (Details Narra

MEZZANINE EQUITY (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended		12 Months Ended
	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2020	Apr. 30, 2022
Debt instrument, face amount		$ 8,800
Stock issued during period, value, new issues
Class of warrant or right, number of securities called by warrants or rights		24,676,571			750,000
Warrant exercise price		$ 0.89
Payments of stock issuance costs			$ 387
Proceeds from issuance or sale of equity	$ 23,000
Payments for construction in process	7,300
Repayments of debt and lease obligation	$ 15,700
Common Stock [Member]
Stock issued during period, shares, new issues			11,413
Hadron Healthcare Master Fund [Member] | Warrant [Member]
Warrant exercise price	$ 1.087
Fair value adjustment of warrants	$ 9,500
Payments of stock issuance costs	$ 400
Hadron Healthcare Master Fund [Member] | Maximum [Member] | Common Stock [Member]
Class of warrant or right, number of securities called by warrants or rights	15,540,540
Securities Purchase Agreement [Member] | Hadron Healthcare Master Fund [Member] | Warrant [Member]
Warrants term	4 years
Series B Convertible Preferred Stock [Member]
Shares issued, price per share		$ 3
Preferred stock, convertible conversion price		$ 3
Preferred stock conversion, description		(ii) the Company has the option to convert all, but not less than all, shares of Series B Stock into common stock at a conversion price of $3.00 if the daily volume weighted average price of common stock (the “VWAP”) exceeds $4.00 per share for at least twenty consecutive trading days prior to the date on which the Company gives notice of such conversion to the Series B Holders.
Series B Convertible Preferred Stock [Member] | Volume Weighted Average Price Less Than Or Equal To $0.50 Per Share [Member]
Preferred stock conversion, description		If the sixty-day VWAP is less than or equal to $0.50 per share, the Company shall have the option to (i) convert all shares of Series B Stock into common stock at a conversion price of $1.00 per share, and pay cash to the Series B Holders equal to the difference between the sixty-day VWAP and $3.00 per share, or (ii) pay cash to the Series B Holders equal to $3.00 per share.
Series B Convertible Preferred Stock [Member] | Volume Weighted Average Price Greater Than $0.50 Per Share [Member]
Preferred stock conversion, description		If the sixty-day VWAP is greater than $0.50 per share, the Company shall have the option to (i) convert all shares of Series B Stock into common stock at a conversion price per share equal to the quotient of $3.00 per share divided by the sixty-day VWAP, or (ii) pay cash to the Series B Holders equal to $3.00 per share, or (iii) convert all shares of Series B Stock into common stock at a conversion price per share equal to the sixty-day VWAP and pay cash to the Series B Holders equal to the difference between $3.00 per share and the sixty-day VWAP.
Series B Convertible Preferred Stock [Member] | Exchange Agreement [Member] | Two Unaffiliated Institutional Shareholders [Member]
Debt instrument, face amount				$ 4,400
Conversion of stock, shares converted				4,908,333
Series C Convertible Preferred Stock [Member] | Hadron Healthcare Master Fund [Member] | Warrant [Member]
Stock issued during period, shares, new issues	6,216,216
Series C Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member] | Hadron Healthcare Master Fund [Member]
Shares issued, price per share	$ 3.70
Stock issued during period, value, new issues	$ 23,000
Series C Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member] | Hadron Healthcare Master Fund [Member] | Maximum [Member]
Stock issued during period, shares, new issues	46,000,000

SCHEDULE OF STOCK OPTIONS ESTIM

SCHEDULE OF STOCK OPTIONS ESTIMATED USING THE BLACK-SCHOLES VALUATION MODEL WITH ASSUMPTIONS (Details)	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Equity [Abstract]
Estimated life (in years)	5 years	5 years
Volatality	98.40%	98.40%
Risk-free interest rates	3%	3%
Dividend yield

STOCKHOLDERS_ EQUITY AND STOC_3

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($)	1 Months Ended					3 Months Ended		6 Months Ended
	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument converted, shares issued								12,542,126	12,542,126
Principal balance	$ 8,800,000					$ 8,800,000		$ 8,800,000
Warrants to purchase of common stock	24,676,571		750,000			24,676,571		24,676,571
Warrants exercise price	$ 0.89					$ 0.89		$ 0.89
Stock option to exericse, shares	312,248							39,899,423
Cashless exercise of stock options, shares					112,248
Stock option exercise price								$ 0.91
Stock option weighted average remaining life								4 years
Stock based compensation						$ 2,600,000	$ 1,200,000	$ 5,000,000	$ 1,600,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument converted, shares issued								1,142,858,000
Restricted common stock issued, shares				375,000		2,717
Restricted common stock issued, value				$ 274,000		$ 2,000
Warrants with held, shares			515,039
Cashless exercise of warrants, shares			234,961
Stock option to exericse, shares								10,000	82,885,000
Warrants and stock option issued, shares					200,000
Common Stock [Member] | Chief Financial Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Restricted common stock issued, shares		350,000
Restricted common stock issued, value		$ 217,000
$8.8 million Promissory Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument converted, shares issued								1,142,858

SCHEDULE OF REVENUES COMPRISED

SCHEDULE OF REVENUES COMPRISED OF MAJOR CATEGORIES (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 32,986	$ 32,569	$ 64,268	$ 57,212
Product Sales Retail [Member]
Disaggregation of Revenue [Line Items]
Total revenue	23,087	20,552	44,528	35,776
Product Sales Wholesale [Member]
Disaggregation of Revenue [Line Items]
Total revenue	7,958	8,178	14,020	13,903
Product Sales [Member]
Disaggregation of Revenue [Line Items]
Total revenue	31,045	28,730	58,548	49,679
Real Estate [Member]
Disaggregation of Revenue [Line Items]
Total revenue	846	1,862	2,433	3,671
Supply Procurement [Member]
Disaggregation of Revenue [Line Items]
Total revenue	820	398	2,010	918
Management Service [Member]
Disaggregation of Revenue [Line Items]
Total revenue	81	981	834	1,877
License and Service [Member]
Disaggregation of Revenue [Line Items]
Total revenue	194	598	443	1,067
Other Revenue [Member]
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,941	$ 3,839	$ 5,720	$ 7,533

MAJOR CUSTOMERS (Details Narrat

MAJOR CUSTOMERS (Details Narrative)	1 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Concentration Risk [Line Items]
Customer contribution			10%	10%	10%	10%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Concentration Risk [Line Items]
Customer accounted contribution	10%	10%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer [Member]
Concentration Risk [Line Items]
Customer accounted contribution	26%	28%

SCHEDULE OF COMPONENTS OF LEASE

SCHEDULE OF COMPONENTS OF LEASE EXPENSE (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Leases
Operating lease expense	$ 298	$ 277	$ 575	$ 544
Amortization of right of use assets	40	8	59	16
Interest on lease liabilities	10	1	17	3
Total finance lease expense	$ 50	$ 9	$ 76	$ 19

SCHEDULE OF FUTURE MINIMUM LEAS

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER ALL NON CANCELABLE OPERATING LEASES (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Lessee, Operating Lease, Liability, to be Paid [Abstract]
Operating Leases, Remainder of 2022	$ 571
Operating Leases, 2023	1,264
Operating Leases, 2024	1,199
Operating Leases, 2025	1,179
Operating Leases, 2026	1,129
Operating Leases, Thereafter	3,214
Operating Lease, Total lease payments	8,556
Less: Operating Leases, Imputed Interest	(2,935)
Operating Leases Liability	5,621
Finance Lease, Liability, to be Paid [Abstract]
Finance Lease, Remainder of 2022	90
Finance Lease, 2023	176
Finance Lease, 2024	153
Finance Lease, 2025	150
Finance Lease, 2026	22
Finance Lease, Thereafter
Finance Lease, Total lease payments	591
Less: Finance Lease, imputed interest	(73)
Finance Lease Liability	$ 518

LEASES (Details Narrative)

LEASES (Details Narrative)	1 Months Ended	6 Months Ended
	Nov. 30, 2021 ft² $ / shares	Jun. 30, 2022 USD ($) ft²	Apr. 30, 2022 ft²	Jun. 30, 2021 ft²
Area of land			14,000	300,000
Lessee, operating lease, description	In November 2021, the Company entered into lease agreements for six retail properties, each with square footage between 4,000 and 6,000 square feet, in the state of Ohio (each an “Ohio Lease” and collectively the “Ohio Leases”). Each Ohio Lease has an initial lease period of eleven months, with a minimum rent of $31.00 per square foot, which amount increases 3.0% annually.
Lessee, operating lease, option to extend		In the event the Company is awarded one or more of the six Ohio cannabis licenses for which it had previously applied, the Company can extend the term of one or more of the Ohio Leases to ten years (with two additional five-year options to extend) upon the payment of $50,000 for each extended Ohio Lease, and develop the premises of such extended lease(s) into a cannabis dispensary.
Operating lease, weighted average remaining lease term		6 years 10 months 24 days
Finance lease, weighted average remaining lease term		3 years 6 months
Lease cost | $ / shares	$ 31
Extended Ohio Lease Agreement [Member]
Lease cost | $		$ 50,000
Minimum [Member]
Area of land	4,000
Operating lease, weighted average discount rate, percent		7.50%
Maximum [Member]
Area of land	6,000
Operating lease, weighted average discount rate, percent		12%
Finance Lease Commitments [Member] | Machinery and Office Equipment [Member]
Lessee, operating lease, description		expire from February 2024 through February 2026
DELAWARE
Area of land		45,000
DELAWARE | Retails Space [Member]
Area of land		4,000
Lessee, operating lease, description		five-year lease that expires in April 2027
DELAWARE | Warehouse [Member]
Area of land		100,000
Lessee, operating lease, description		The lease expires in March 2030, with an option to extend the term for three additional years
DELAWARE | Cultivation and Processing Facility [Member]
Area of land		60,000
DELAWARE | Premises [Member]
Area of land		12,000
Lessee, operating lease, description		The lease expires in January 2026 and contains an option to negotiate an extension at the end of the lease
NEVADA | Industrial Building [Member]
Area of land		10,000
Lessee, operating lease, description		lease expiring in 2024
MASSACHUSETTS
Area of land		138,000
MASSACHUSETTS | Office Space [Member]
Area of land		10,000
Lessee, operating lease, description		expiring in 2028
Lessee, operating lease, option to extend		option to extend the term for an additional five-year period
MARYLAND
Area of land		180,000
MARYLAND | Two Unit Apartment [Member]
Area of land		2,700
Lessee, operating lease, description		expires in July 2023

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Operating lease, expense	$ 39,000	$ 39,000	$ 78,000	$ 78,000
Payments to acquire property, plant, and equipment			7,854,000	7,976,000
Payments to acquire fixed assets and consulting services	267,000	308,000	$ 659,000	573,000
Bettys Eddies Products [Member] | Royalty Agreement [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Royalty percentage description			the royalty percentage changed from 2.5% on all sales of Betty’s Eddies products to (i) 3.0% and 10.0% of wholesale sales of existing products within the product line if sold directly by the Company, or licensed by the Company for sale by third parties, respectively, and (ii) 0.5% and 1.0% of wholesale sales of future developed products within the product line if sold directly by the Company, or licensed by the Company for sale by third-parties, respectively
Accrued royalties	53,000	79,000	$ 109,000	162,000
Chief Operating Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Payments to acquire property, plant, and equipment	1,400,000	1,200,000	2,300,000	2,000,000
CEO and CAO [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Payments to acquire additional interest in subsidiaries	12,600	12,000	23,100	21,000
Current Employee [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Payments to acquire additional interest in subsidiaries	8,000		11,000
Employee [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Payments to acquire property, plant, and equipment	$ 278,000	$ 156,000	$ 360,000	$ 466,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		1 Months Ended
	Apr. 20, 2022	Jan. 31, 2022	May 31, 2020	Dec. 31, 2019
OGGUSA Debtors [Member]
Bankruptcy filed	$ 200,000	$ 40,000	$ 33,600,000
Bankruptcy claimed by court			$ 31,000,000
GenCanna Global Inc. [Member]
Related party receivable				$ 29,000,000
GenCanna Global Inc. [Member] | Ownership Interest [Member]
Percentage Owned				33.50%

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Mari Holdings Mt Vernon LLC [Member] - DuQuoin State Bank [Member] - Subsequent Event [Member] $ in Millions	Jul. 31, 2022 USD ($)
Subsequent Event [Line Items]
Loans agreements and mortgages	$ 3
Loan terms	20 years
Prime Rate [Member]
Subsequent Event [Line Items]
Initial rate of interest	7.75%
Floor Rate [Member]
Subsequent Event [Line Items]
Initial rate of interest	7.75%